• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    Computer Concepts for Medical Device Design

    IVD Manufacturers Are Being Put to the Test

    The New State of Medtech Outsourcing

    The Changing Face of Medtech Surface Treatment

    The Totally Tubular Technologies that Support Medical Devices
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Regulatory
    Financial/Business
    Top News
    CareDx, Miromatrix Collaborate on Bioengineered Organs Research

    Capitainer Releases to Market its Fully Automated Sample Handler

    Titan Medical Licenses Most IP to Intuitive; CEO Steps Down

    Nox Medical Secures New Patent for Calculating Respiratory Effort During Sleep Studies

    Concept Medical Earns 4th FDA IDE Nod for MagicTouch PTA
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    Computer Concepts for Medical Device Design

    IVD Manufacturers Are Being Put to the Test

    The New State of Medtech Outsourcing

    The Changing Face of Medtech Surface Treatment

    The Totally Tubular Technologies that Support Medical Devices
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Checking Up on Surgical Robotics

    Building a Network: How Synchron Is Developing a New Device—and a New Market

    Six Lessons Learned on Developing a Strong Company Culture

    As Hiring Slows, Companies Look Inward to Fulfill Talent Needs

    Artificial Intelligence: Medtech Opportunity or Health Danger?
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    NDH Medical Inc.

    Fusion Biotec Inc.

    Providence Enterprise USA Inc.

    LEMO USA Inc.

    JBC Technologies
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    6 Considerations for Companies on the Cusp of Being Acquired

    3 Key Elements to Consider When Managing a Medtech Sales Force

    Tech-Enabled Virtual Speech Therapy Improves Speech & Communication Skills

    Practical Strategies for Digitization and Integration in Medtech Manufacturing

    Sensors: The Heart of Minimally Invasive Equipment Technology
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    NDH Medical Inc.

    Fusion Biotec Inc.

    Providence Enterprise USA Inc.

    LEMO USA Inc.

    JBC Technologies
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • eBook
    • Resources
    • Podcasts
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Breaking News

    ALung Receives IDE Approval to Conduct VENT-AVOID Trial of the Hemolung RAS for the U.S. Market

    Trial will validate the safety and efficacy of the Hemolung Respiratory Assist System for COPD patients.

    ALung Receives IDE Approval to Conduct VENT-AVOID Trial of the Hemolung RAS for the U.S. Market
    The Hemolung RAS is an investigational device from ALung Technologies which provides extracorporeal carbon dioxide removal for patients with acute respiratory failure due to acute exacerbation of COPD. Photo courtesy of Business Wire.
    Business Wire10.16.17
    ALung Technologies Inc. has announced U.S. Food and Drug Administration (FDA) approval of its Investigational Device Exemption (IDE) to conduct a pivotal clinical trial of the Hemolung Respiratory Assist System for the treatment of adults with severe acute exacerbation of chronic obstructive pulmonary disease (COPD). The FDA’s approval of the IDE makes ALung’s VENT-AVOID Trial the first pivotal trial of extracorporeal carbon dioxide removal (ECCO2R) for treating patients with COPD exacerbations.
     
    “The achievement of FDA approval for initiation of the VENT-AVOID Trial is an important milestone towards making the Hemolung RAS and ECCO2R therapy available to U.S. patients and their physicians,” said Peter DeComo, chairman and CEO of ALung. “We believe there is great potential for the Hemolung technology to facilitate ventilator avoidance, resulting in improved clinical outcomes and a lower cost of care through a reduction in length of stay in the intensive care unit.”
     
    The VENT-AVOID Trial is a prospective, multi-center, randomized, controlled, pivotal trial to validate the safety and efficacy of the Hemolung Respiratory Assist System for COPD patients experiencing an acute exacerbation requiring ventilatory support. Forty hospitals will enroll up to 800 patients in the trial. The study protocol is built around an adaptive statistical plan which will allow for PMA submission when early success criteria are reached, potentially with as few as 300 patients enrolled. COPD patients suffering severe exacerbations will be eligible for the study if they are either 1) failing non-invasive ventilation and presenting a high risk of being intubated and mechanically ventilated or 2) have required intubation and invasive mechanical ventilation due to acute respiratory failure. Serving as the study principal investigator is Dr. Nicholas Hill, M.D., chief, Division of Pulmonary, Critical Care and Sleep Medicine at Tufts Medical Center. Hill is an international leader in pulmonary critical care medicine, having led studies which established non-invasive ventilation as the standard of care for COPD exacerbations.
     
    In addition to the U.S.-based VENT-AVOID study, the Hemolung RAS is also being studied in a landmark pivotal study for patients with acute respiratory distress syndrome (ARDS) as part of the 1,120-patient REST Trial in the United Kingdom. “Our commitment to clinical science runs very deep,” added DeComo. “We will soon be the only company participating in not just one, but two major pivotal trials validating the safety and efficacy of extracorporeal carbon dioxide removal therapy provided by the Hemolung RAS.”
     
    ALung worked collaboratively with the FDA under its Expedited Access Pathway (EAP) program to obtain IDE approval. The Expedited Access Pathway is a new FDA program aimed to facilitate more rapid patient access to breakthrough technologies intended to treat or diagnose life-threatening or irreversibly debilitating diseases or conditions. ALung will continue to collaborate with the FDA during study enrollment and through the PMA process.
     
    COPD affects 30 million Americans1 and is the third leading cause of death in the United States behind cancer and heart disease.2 Acute exacerbations, defined as a sudden worsening of COPD symptoms, are a major cause of morbidity and mortality in COPD patients. For patients with severe exacerbations, high levels of carbon dioxide can result in respiratory failure and the need for intubation and mechanical ventilation as life saving measures. Unfortunately, mechanical ventilation is associated with many side effects, and in-hospital mortality remains as high as 30 percent. ECCO2R therapy with the Hemolung RAS allows carbon dioxide to be removed from the blood independently of the lungs with the aim of facilitating the avoidance or reduction of intubation and invasive mechanical ventilation.
     
    ALung was founded in 1997 by Dr. William Federspiel, professor of bioengineering at the University of Pittsburgh, and the late Dr. Brack Hattler, a renowned cardiothoracic surgeon. Federspiel and his team at the University’s Medical Devices Laboratory, part of the McGowan Institute for Regenerative Medicine, developed the original Hemolung technology, which was subsequently licensed by ALung for commercial development. The Hemolung RAS has been approved outside of the United States since 2013 and is commercially available in major European markets.
     
    ALung Technologies Inc. is a privately-held Pittsburgh, Pa.-based developer and manufacturer of lung assist devices. Founded in 1997 as a spin-out of the University of Pittsburgh, ALung has developed the Hemolung RAS as a dialysis-like alternative or supplement to mechanical ventilation. ALung is backed by Philips, UPMC Enterprises, Abiomed, The Accelerator Fund, Allos Ventures, Birchmere Ventures, Blue Tree Ventures, Eagle Ventures, Riverfront Ventures, West Capital Advisors, and other individual investors. The Hemolung RAS is an investigational device and limited by United States law to investigational use.
     
    References
    1. https://www.copdfoundation.org/What-is-COPD/COPD-Facts/Statistics.aspx
    2. http://www.lung.org/assets/documents/research/copd-trend-report.pdf
    Related Searches
    • clinical trial
    • intubation
    • ceo
    • heart
    Suggested For You
    Regality Consulting LLC Regality Consulting LLC
    BioStable Science Announces First Commercial Use of the HAART 200 Aortic Annuloplasty Device BioStable Science Announces First Commercial Use of the HAART 200 Aortic Annuloplasty Device
    FDA Clears Masimo FDA Clears Masimo's Rad-97 Pulse CO-Oximeter
    NaviENT Receives FDA 510(K) Clearance NaviENT Receives FDA 510(K) Clearance
    NICE Announces Interventional Procedure Guidance Supporting Hydrogel Spacer Use in Cancer Treatment NICE Announces Interventional Procedure Guidance Supporting Hydrogel Spacer Use in Cancer Treatment
    MDUFA IV and Its Impact on Medtech Innovation—Mike on Medtech MDUFA IV and Its Impact on Medtech Innovation—Mike on Medtech
    FDA Warns US Stem Cell Clinic of Significant Deviations FDA Warns US Stem Cell Clinic of Significant Deviations
    An Examination of User Fees’ Impact on Review Times An Examination of User Fees’ Impact on Review Times
    Off-Label Use—Mike on Medtech Off-Label Use—Mike on Medtech
    FDA Clears BioStable Science & Engineering FDA Clears BioStable Science & Engineering's Aortic Annuloplasty Device
    Recall: Intra-Aortic Balloon Pumps Carry Risk of Valve Failure Recall: Intra-Aortic Balloon Pumps Carry Risk of Valve Failure
    Samsung Releases BodyTom Elite CT Scanner Samsung Releases BodyTom Elite CT Scanner
    Masimo Masimo's rainbow Super Sensor Gains CE Mark
    FDA Approves EnvisionTEC FDA Approves EnvisionTEC's E-Denture Material to 3D Print Removables
    FDA Clears Siemens Healthineers FDA Clears Siemens Healthineers' MAGNETOM Vida 3T MRI System

    Related Buyers Guide Companies

    • Regality Consulting LLC

      ...
      James Gianoutsos, Founder & Principal Consultant 10.20.17

    • Cardiovascular
      BioStable Science Announces First Commercial Use of the HAART 200 Aortic Annuloplasty Device

      BioStable Science Announces First Commercial Use of the HAART 200 Aortic Annuloplasty Device

      Product expands surgeons' ability to offer valve repair as an alternative to valve replacement.
      Business Wire 10.11.17

    • Patient Monitoring
      FDA Clears Masimo

      FDA Clears Masimo's Rad-97 Pulse CO-Oximeter

      Compact, standalone monitor incorporates advanced customizability, connectivity, and device integration capabilities.
      Business Wire 09.18.17


    • Surgical
      NaviENT Receives FDA 510(K) Clearance

      NaviENT Receives FDA 510(K) Clearance

      Image-guided surgical navigation system helps ENT surgeons with identifying anatomic structures in transnasal interventions.
      ClaroNav 09.11.17

    • NICE Announces Interventional Procedure Guidance Supporting Hydrogel Spacer Use in Cancer Treatment

      NICE Announces Interventional Procedure Guidance Supporting Hydrogel Spacer Use in Cancer Treatment

      Decision based on data involving use of SpaceOAR hydrogel to protect surrounding tissue during radiotherapy.
      Business Wire 09.11.17

    Loading, Please Wait..

    Trending
    • AVS Collects An Additional $8.8 Million In Its Series B Funding Round
    • Philips Names New Supervisory Board Chairman
    • Healthcare Changes Prompt Medtronic To Merge Sales Force Medtronic, Inc. Is Combining Its U.S. Ca
    • Medtronic To Buy Wearable Insulin Patch Maker EOFlow For $738M
    • Noah Medical's Galaxy System Achieves First U.S. Robotic Bronchoscopy
    Breaking News
    • CareDx, Miromatrix Collaborate on Bioengineered Organs Research
    • Capitainer Releases to Market its Fully Automated Sample Handler
    • Titan Medical Licenses Most IP to Intuitive; CEO Steps Down
    • Nox Medical Secures New Patent for Calculating Respiratory Effort During Sleep Studies
    • Concept Medical Earns 4th FDA IDE Nod for MagicTouch PTA
    View Breaking News >
    CURRENT ISSUE

    May 2023

    • Computer Concepts for Medical Device Design
    • IVD Manufacturers Are Being Put to the Test
    • The New State of Medtech Outsourcing
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Verdure Sciences Receives Award for Sustainable, Ethical Turmeric Sourcing
    BGG Receives Patent for Saw Palmetto ID Method
    Premium Label & Packaging Solutions Receives Safe Quality Food (SQF) Certification
    Coatings World

    Latest Breaking News From Coatings World

    Boeing Starts Construction on New St. Louis Facility
    Brand Finance: Post-COVID Recovery Slows for Chemicals Industry Battling Energy Crisis
    BCF Calls for Greater Urgency on REACH Impasse
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    CareDx, Miromatrix Collaborate on Bioengineered Organs Research
    Capitainer Releases to Market its Fully Automated Sample Handler
    Titan Medical Licenses Most IP to Intuitive; CEO Steps Down
    Contract Pharma

    Latest Breaking News From Contract Pharma

    AVROBIO Sells Cystinosis Gene Therapy for $87.5 Million
    Meiji Seika Pharma, Adcock Ingram Pharma Complete Construction of New Manufacturing Facility
    JSR Life Sciences Consolidates KBI Biopharma and Selexis SA
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Unilever Uses AI for Product Development
    Beautycounter Names New Interim CEO
    Shaz & Kiks Available at Sephora
    Happi

    Latest Breaking News From Happi

    Covergirl Introduces Clean Fresh Yummy Gloss Collection
    Shaz and Kiks Launches at Sephora
    Beautycounter Appoints Board Director Mindy Mackenzie Interim CEO
    Ink World

    Latest Breaking News From Ink World

    ACTEGA, Makro Labelling to Advance Signite Technology
    BCF Requests Greater Urgency on REACH Impasse
    Updated Method Published for Entire BASF Product Portfolio
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    ACTEGA teams with Makro Labelling to advance Signite technology
    Constantia Flexibles and SB Packagings commence joint venture
    Inland donates new VersaStudio printer to local high school
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Mann+Hummel Names President Air Filtration Americas
    KNH Launches Eco-Friendly Menstrual Pads
    Niine Introduces India's First PLA-Based Sanitary Pads
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Enrollment Completed in Anika Therapeutics' Hyalofast Study
    Exactech Releases Next-Gen GPS Shoulder
    Data Shows Favorable Survivorship of MISHA Knee System & Reduction of Arthroplasty Risk in Patients
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    onsemi Presents Path to Accelerate Revenue Growth
    STMicroelectronics Introduces Waterproof MEMS Pressure Sensor
    Graphene Flagship to Join Euro Nano Forum 2023

    Copyright © 2023 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login